> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biologic and Radiopharmaceutical Drugs Directorate
- URL: https://www.whiteroseintelligence.com/biologic-and-radiopharmaceutical-drugs-directorate/
- Published: 2026-06-13T18:12:00.000Z
- Updated: 2026-06-13T18:13:37.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization, Organization, COVID-19, #toc, Government, Regulatory, Canada, Ontario, Pharmaceutical, Biotechnology

The **Biologic and Radiopharmaceutical Drugs Directorate (BRDD)**, previously known as the **Biologics and Genetic Therapies Directorate (BGTD)**, is a Canadian regulatory directorate based in Ottawa, Ontario. It is a subsidiary of the [Health Products and Food Branch](https://www.whiteroseintelligence.com/Health-Products-and-Food-Branch) (HPFB) of [Health Canada](https://www.whiteroseintelligence.com/Health-Canada).[\[1\]](#fn1)

## History

In early 2020, the Biologics and Genetic Therapies Directorate changed its name to the Biologic and Radiopharmaceutical Drugs Directorate.[\[2\]](#fn2)

### COVID-19

Between October 9, 2020 and February 19, 2026, BRDD reviewed 189 submissions for [COVID-19 vaccine](https://www.whiteroseintelligence.com/COVID-19-vaccine) candidates.[\[3\]](#fn3)

## Organization

BRDD is made up of several centres and offices:

- Centre for Biologics Evalution (CBE)
- [Centre for Oncology, Radiopharmaceuticals and Research](https://www.whiteroseintelligence.com/Centre-for-Oncology-Radiopharmaceuticals-and-Research)

### Personnel

| Name                                                             | Position                                                             | Notes                                                                                                                                                                                                                                                                                    |
| ---------------------------------------------------------------- | -------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Sophie Sommerer                                                  | Director General[\[4\]](#fn4)                                        | [Marketed Health Products Directorate](https://www.whiteroseintelligence.com/Marketed-Health-Products-Directorate), Therapeutics Products Directorate (TPD), First Nations and Inuit Health Branch, Centre for Health Promotion (CHP), Strategic Initiatives and Innovations Directorate |
| Christopher Antonio                                              | Manager, Office of Regulatory Affairs[\[5\]](#fn5)                   | \-                                                                                                                                                                                                                                                                                       |
| Léo Bouthillier                                                  | Director[\[6\]](#fn6)                                                | \-                                                                                                                                                                                                                                                                                       |
| Agnes Klein                                                      | Senior Medical Advisor[\[7\]](#fn7)                                  | Drug Information Association (DIA)                                                                                                                                                                                                                                                       |
| Manon Poulin                                                     | Management Executive Assistant / Administrative Officer[\[8\]](#fn8) | \-                                                                                                                                                                                                                                                                                       |
| Julie Wallace                                                    | Manager, Office of Regulatory Affairs[\[9\]](#fn9)                   | Biologics and Genetic Therapies Directorate                                                                                                                                                                                                                                              |
| [Lucia Zhang](https://www.whiteroseintelligence.com/Lucia-Zhang) | Senior Clinical Evaluator[\[10\]](#fn10)[\[11\]](#fn11)              | American Society for Pharmacology and Experimental Therapeutics, American Society for Bone and Mineral Research                                                                                                                                                                          |

---

1. Health Canada. (2020, October 20). *Biologic and Radiopharmaceutical Drugs Directorate.* Government of Canada. <http://archive.today/2021.06.02-181514/https://www.canada.ca/en/health-canada/corporate/about-health-canada/branches-agencies/health-products-food-branch/biologic-radiopharmaceutical-drugs-directorate.html> [↩︎](#fnref1)
2. *Biologic and Radiopharmaceutical Drugs Directorate Drug Submission Performance Annual Report Fiscal Year 2019-2020 - April 1 2019 – March 31 2020.* (2020, July). Health Canada. <https://publications.gc.ca/collections/collection%5F2020/sc-hc/H166-5-2020-eng.pdf> [↩︎](#fnref2)
3. Lamoureux, K. (2026, May 29). *Response from May 29, 2026 for Q-1037.* House of Commons of Canada. [https://www.ourcommons.ca/written-questions/45-1/q-1037/14130753?showQuestion=true§ion=all](https://www.ourcommons.ca/written-questions/45-1/q-1037/14130753?showQuestion=true%C2%A7ion=all) [↩︎](#fnref3)
4. *Experience | Sophie Sommerer.* LinkedIn. Retrieved February 24, 2024, from <https://www.linkedin.com/in/sophie-sommerer-8845a513/details/experience/> [↩︎](#fnref4)
5. *Christopher Antonio · Health Canada · Manager.* OpenGovCA. Retrieved November 26, 2023, from <https://web.archive.org/web/20231126235401/https://opengovca.com/employee/christopher-antonio> [↩︎](#fnref5)
6. Rencheck, M. (2023, November 14). *Monthly Communication Report - 928062-5776-33.* Office of the Commissioner of Lobbying of Canada. <http://archive.today/2023.11.26-232600/https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/cmmLgPblcVw?comlogId=507862> [↩︎](#fnref6)
7. *Agnes Klein.* LinkedIn. Retrieved February 24, 2024, from <https://www.linkedin.com/in/agnes-klein-98a1246/> [↩︎](#fnref7)
8. *Person Information - Manon L Poulin.* (2020, October 10). Government of Canada. <http://archive.today/2023.11.26-233233/https://new.geds-sage.gc.ca/en/GEDS/?pgid=015&dn=Q049TUFOT04uTC5QT1VMSU5ASEMtU0MuR0MuQ0EsT1U9REdPLUJERyxPVT1CUkRELURNQlIsT1U9SFBGQi1ER1BTQSxPVT1IQy1TQyxPPUdDLEM9Q0E=> [↩︎](#fnref8)
9. *Experience | Julie Wallace.* LinkedIn. Retrieved November 26, 2023, from <http://archive.today/2023.11.26-234442/https://www.linkedin.com/in/julie-wallace-25371a14/details/experience/> [↩︎](#fnref9)
10. *Lucia Zhang.* LinkedIn. Retrieved May 27, 2023, from <http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/> [↩︎](#fnref10)
11. *Lucia Zhang · Health Canada · Clinical Evaluator.* OpenGovCa. Retrieved May 27, 2023, from <https://web.archive.org/web/20230527053643/https://opengovca.com/employee/lucia-zhang> [↩︎](#fnref11)